Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Recent research reveals that anti-inflammatory inhalers not only cut the risk of severe asthma complications but also offer modest improvements in symptom control compared to traditional ...

Terbutaline is still used, but the brand name is no longer available ... As a rule of thumb, if you need to use a rescue inhaler more than twice weekly, your asthma is being poorly controlled.

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...

As with rescue inhalers, there are combination inhalers that combine LABAs with LAMAs, LABAs with ICS, and LABAs with LAMAs and ICS. Using these drugs in combination can often improve long-term ...

Despite these and other positive pieces of evidence provided by publications in the last decade, inhaled CS have not been considered effective in treating asthma exacerbations. Different state-of ...

SABAs are often called rescue inhalers ... has approved two SABAs for treating asthma, both of which are available in generic form as well as under brand names: ß2-agonists mimic two hormones ...

After many trips to the doctor's office, five-year-old Burton Hayes's asthma was finally under control with ... In addition, ...

Take the market for albuterol inhalers, filled with fast-acting drugs meant to stop an asthma attack in its tracks. Before the propellant switch, annual sales for the three brand-name inhalers had ...

Clinical evidence shows that inhaled CS present early benefits (within 1-2 h) for the treatment of children and adults with acute asthma. Patients (children and adults) who received inhaled CS ...